Price target
500.800.000.00%
The 17 analysts offering 1 year price forecasts for 0Q4U have a max estimate of — and a min estimate of —.
Analyst rating
Based on 18 analysts giving stock ratings to 0Q4U in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
0Q4U EPS for the last quarter is 4.63 DKK despite the estimation of 4.40 DKK. In the next quarter EPS is expected to reach 3.83 DKK. Track more of NOVONESIS (NOVOZYMES) B SER'B'DKK2 financials and stay on top of what is up with the company.
In the next quarter NOVONESIS (NOVOZYMES) B SER'B'DKK2 revenue is expected to reach 7.51 B DKK. Check out NOVONESIS (NOVOZYMES) B SER'B'DKK2 revenue and earnings and make informed decisions.
According to analysts, 0Q4U price target is 500.80 DKK with a max estimate of 576.64 DKK and a min estimate of 361.00 DKK. Check if this forecast comes true in a year, meanwhile watch NOVONESIS (NOVOZYMES) B SER'B'DKK2 stock price chart and keep track of the current situation with 0Q4U news and stock market news.
We've gathered opinions of 18 analysts rating 0Q4U stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.